相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors
Naoko Takebe et al.
CLINICAL CANCER RESEARCH (2021)
Gold(I) Complexes with a Quinazoline Carboxamide Alkynyl Ligand: Synthesis, Cytotoxicity, and Mechanistic Studies
Leila Tabrizi et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2021)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurelie Kamoun et al.
EUROPEAN UROLOGY (2020)
Sex Differences in Urothelial Bladder Cancer Survival
Cecilia Radkiewicz et al.
CLINICAL GENITOURINARY CANCER (2020)
Tubulin Inhibitors Binding to Colchicine-Site: A Review from 2015 to 2019
Lin-Ying Xia et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Synthesis and screening of novel anthraquinone-quinazoline multitarget hybrids as promising anticancer candidates
Dandan Liang et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Updates in Staging and Reporting of Genitourinary Malignancies
Kristine M. Cornejo et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect
Jiansong Han et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)
Parth Bhatia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
Meredith Mihalopoulos et al.
CANCERS (2020)
Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids
Prashant S. Auti et al.
RSC ADVANCES (2020)
Evaluation of antitumor potential of synthesized novel 2-substituted 4-anilinoquinazolines as quinazoline-pyrrole hybrids in MCF-7 human breast cancer cell line and A-549 human lung adenocarcinoma cell lines
Raju Bathula et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Discovery of Hybrid Purine-quinoline Molecules and Their Cytotoxic Evaluation
Khushal M. Kapadiya et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2019)
Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain
Wenlong Li et al.
BIOORGANIC CHEMISTRY (2019)
Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids
Md. Maqusood Alam et al.
BIOORGANIC CHEMISTRY (2019)
Hope and challenge: Precision medicine in bladder cancer
Hongwei Su et al.
CANCER MEDICINE (2019)
Genotoxicity and mutagenicity of nickel(II) and iron(III) and interactions between these microelements
Katarzyna Czarnek et al.
TRACE ELEMENTS AND ELECTROLYTES (2019)
Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
Dongkui Song et al.
JOURNAL OF PATHOLOGY (2019)
Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells
Yue-peng Cao et al.
ACTA PHARMACOLOGICA SINICA (2019)
Current Cancer Epidemiology
Camilla Mattiuzzi et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2019)
Overview of the LUX-Lung clinical trial program of afatinib for non-small cell lung cancer
Namita Sharma et al.
CANCER TREATMENT REVIEWS (2018)
Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
M. Faehling et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer A meta-analysis
Wenxiong Zhang et al.
MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines
Kosei Sakai et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Design, synthesis and evaluation of novel hybrids between 4-anilinoquinazolines and substituted triazoles as potent cytotoxic agents
Giang Le-Nhat-Thuy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
A Novel Quinazoline Derivative, MJ-56, Exhibits Phototoxicity toward Human Bladder Cancer Cells
Hung-En Chen et al.
UROLOGICAL SCIENCE (2018)
Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
Yanjun Huang et al.
CANCER COMMUNICATIONS (2018)
Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents
Md. Maqusood Alam et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent
Biswadip Banerji et al.
ACS OMEGA (2018)
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Sebastien Antoni et al.
EUROPEAN UROLOGY (2017)
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells
Guo-Hai Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, Cytotoxic Activity Evaluation of Novel 1,2,3-Triazole Linked Quinazoline Derivatives
Panpan Song et al.
CHINESE JOURNAL OF CHEMISTRY (2017)
Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer
Max Kates et al.
CLINICAL CANCER RESEARCH (2017)
Benzodiazines: recent synthetic advances
Thomas Mathew et al.
CHEMICAL SOCIETY REVIEWS (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Quinazolinones-Phenylquinoxaline hybrids with unsaturation/saturation linkers as novel anti-proliferative agents
Jyothsna Devi Palem et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line
Jung Hun Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Cancer immunotherapy: new applications in urologic oncology
Michael E. Hurwitz et al.
CURRENT OPINION IN UROLOGY (2016)
Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC
Fan-Wei Peng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents
Wei Peng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer
Poupak Fallahi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
Mei Peng et al.
SCIENTIFIC REPORTS (2016)
Design, Synthesis and In Vitro Antiproliferative Activity of Novel Isatin-Quinazoline Hybrids
Mohamed Fares et al.
ARCHIV DER PHARMAZIE (2015)
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
R. T. Bryan et al.
BRITISH JOURNAL OF CANCER (2015)
Selected aspects of the action of cobalt ions in the human body
Katarzyna Czarnek et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Maintenance Therapy with 3-monthly Bacillus Calmette-Guerin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013
Luis Martinez-Pineiro et al.
EUROPEAN UROLOGY (2015)
Nonurothelial Bladder Cancer and Rare Variant Histologies
Daniel Willis et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Quinazoline-benzimidazole hybrid as dual optical sensor for cyanide and Pb2+ ions and Aurora kinase inhibitor
Vijay Luxami et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2015)
Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics
Stefan Vallo et al.
TRANSLATIONAL ONCOLOGY (2015)
Promises and challenges of fluorescence cystoscopy
Yair Lotan
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Functional role of G9a histone methyltransferase in cancer
Francesco Casciello et al.
FRONTIERS IN IMMUNOLOGY (2015)
BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer In Vivo
Chong Li et al.
CLINICAL CANCER RESEARCH (2014)
Mitochondrial protein targets of radiosensitisation by 1,8-dihydroxy-3-acetyl-6-methyl-9,10 anthraquinone on nasopharyngeal carcinoma cells
Yuanyuan Mo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
International Variations in Bladder Cancer Incidence and Mortality
Saurabh Chavan et al.
EUROPEAN UROLOGY (2014)
Myths and Mysteries Surrounding Bacillus Calmette-Guerin Therapy for Bladder Cancer
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives
Mohammad Asif
INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY (2014)
Anticancer mechanisms and clinical application of alkylphospholipids
Wim J. van Blitterswijk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids
Alka Sharma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII
Jaroslaw Slawinski et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
PD-1 as a potential target in cancer therapy
David F. McDermott et al.
CANCER MEDICINE (2013)
Investigating the relationship between virtual cystoscopy image quality and CT slice thickness
S. Lalondrelle et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
Urinary Bladder Cancer: Role of MR Imaging
Sadhna Verma et al.
RADIOGRAPHICS (2012)
Cytotoxicity and anti-HIV evaluations of some new synthesized quinazoline and thioxopyrimidine derivatives using 4-(thiophen-2-yl)-3,4,5,6-tetrahydrobenzo[h]quinazoline-2(1H)-thione as synthon
Yahia A. Mohamed et al.
JOURNAL OF CHEMICAL SCIENCES (2012)
Metastatic Pattern of Bladder Cancer: Correlation With the Characteristics of the Primary Tumor
Atul B. Shinagare et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome
David Lindgren et al.
CANCER RESEARCH (2010)
Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents
Saleh I. Alqasoumi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer
Paolo Gontero et al.
EUROPEAN UROLOGY (2010)
Screening Agents for Preventive Efficacy in a Bladder Cancer Model: Study Design, End Points, and Gefitinib and Naproxen Efficacy
Ronald A. Lubet et al.
JOURNAL OF UROLOGY (2010)
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells
Lynsey A. McHugh et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Apoptosis induction by doxazosin and other quinazoline α1-adrenoceptor antagonists: a new mechanism for cancer treatment?
Natasha Kyprianou et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia
Gudmar Loennerholm et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Microenvironmental regulation of cancer development
Min Hu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
New symmetrical quinazoline derivatives selectively induce apoptosis in human cancer cells
Elena Cubedo et al.
CANCER BIOLOGY & THERAPY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder
A Tahmatzopoulos et al.
UROLOGY (2005)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
Receptor tyrosine kinases as target for anti-cancer therapy
S Brunelleschi et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
分享论文
